Literature DB >> 29593077

Selective screening for atrial fibrillation using multivariable risk models.

David T Linker1, Tasha B Murphy2, Ali H Mokdad3.   

Abstract

OBJECTIVE: Atrial fibrillation can lead to stroke if untreated, and identifying those at higher risk is necessary for cost-effective screening for asymptomatic, paroxysmal atrial fibrillation. Age has been proposed to identify those at risk, but risk models may provide better discrimination. This study compares atrial fibrillation risk models with age for screening for atrial fibrillation.
METHODS: Nine atrial fibrillation risk models were compared using the Atherosclerosis Risk in Communities study (11 373 subjects, 60.0±5.7 years old). A new risk model (Screening for Asymptomatic Atrial Fibrillation Events-SAAFE) was created using data collected in the Monitoring Disparities in Chronic Conditions study (3790 subjects, 58.9±15.3 years old). The primary measure was the fraction of incident atrial fibrillation subjects who should receive treatment due to a high CHA2DS2-VASc score identified when screening a fixed number equivalent to the age criterion. Secondary measures were the C statistic and net benefit.
RESULTS: Five risk models were significantly better than age. Age identified 71 (61%) of the subjects at risk for stroke who subsequently developed atrial fibrillation, while the best risk model identified 96 (82%). The newly developed SAAFE model identified 95 (81%), primarily based on age, congestive heart failure and coronary artery disease.
CONCLUSIONS: Use of a risk model increases identification of subjects at risk for atrial fibrillation. One of the best performing models (SAAFE) does not require an ECG for its application, so that it could be used instead of age as a screening criterion without adding to the cost. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  atrial fibrillation; cardiac risk factors and prevention; stroke

Mesh:

Substances:

Year:  2018        PMID: 29593077     DOI: 10.1136/heartjnl-2017-312686

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  11 in total

1.  Arrhythmia Detection is Improved by 14-Day Continuous Electrocardiography Patch Monitoring and CHA2DS2-VASc Score.

Authors:  Yu-Wen Cheng; Lung-Sheng Wu; Chia-Tung Wu; Chia-Pin Lin; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2022-01       Impact factor: 2.672

2.  C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.

Authors:  Yan-Guang Li; Arnaud Bisson; Alexandre Bodin; Julien Herbert; Leslie Grammatico-Guillon; Boyoung Joung; Yu-Tang Wang; Gregory Y H Lip; Laurent Fauchier
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

Review 3.  Screening for atrial fibrillation: a call for evidence.

Authors:  Nicholas R Jones; Clare J Taylor; F D Richard Hobbs; Louise Bowman; Barbara Casadei
Journal:  Eur Heart J       Date:  2020-03-07       Impact factor: 29.983

4.  Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis.

Authors:  Jelle C L Himmelreich; Lieke Veelers; Wim A M Lucassen; Renate B Schnabel; Michiel Rienstra; Henk C P M van Weert; Ralf E Harskamp
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

5.  CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening.

Authors:  Jelle C L Himmelreich; Wim A M Lucassen; Ralf E Harskamp; Claire Aussems; Henk C P M van Weert; Mark M J Nielen
Journal:  Open Heart       Date:  2021-01

6.  Utility of risk prediction models to detect atrial fibrillation in screened participants.

Authors:  Michiel H F Poorthuis; Nicholas R Jones; Paul Sherliker; Rachel Clack; Gert J de Borst; Robert Clarke; Sarah Lewington; Alison Halliday; Richard Bulbulia
Journal:  Eur J Prev Cardiol       Date:  2021-05-22       Impact factor: 8.526

7.  Validating risk models versus age alone for atrial fibrillation in a young Dutch population cohort: should atrial fibrillation risk prediction be expanded to younger community members?

Authors:  Jelle C L Himmelreich; Ralf E Harskamp; Bastiaan Geelhoed; Saverio Virdone; Wim A M Lucassen; Ron T Gansevoort; Michiel Rienstra
Journal:  BMJ Open       Date:  2022-02-16       Impact factor: 2.692

8.  Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.

Authors:  Ramesh Nadarajah; Eman Alsaeed; Ben Hurdus; Suleman Aktaa; David Hogg; Matthew G D Bates; Campbel Cowan; Jianhua Wu; Chris P Gale
Journal:  Heart       Date:  2022-06-10       Impact factor: 7.365

9.  Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Retrospective Cohort.

Authors:  Eulalia Muria-Subirats; Josep Lluis Clua-Espuny; Juan Ballesta-Ors; Blanca Lorman-Carbo; Iñigo Lechuga-Duran; Jose Fernández-Saez; Roger Pla-Farnos
Journal:  Int J Environ Res Public Health       Date:  2020-05-16       Impact factor: 4.614

10.  Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial.

Authors:  Nathan R Hill; Chris Arden; Lee Beresford-Hulme; A John Camm; David Clifton; D Wyn Davies; Usman Farooqui; Jason Gordon; Lara Groves; Michael Hurst; Sarah Lawton; Steven Lister; Christian Mallen; Anne-Celine Martin; Phil McEwan; Kevin G Pollock; Jennifer Rogers; Belinda Sandler; Daniel M Sugrue; Alexander T Cohen
Journal:  Contemp Clin Trials       Date:  2020-10-19       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.